Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
Standard
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. / Lannering, Birgitta; Rutkowski, Stefan; Doz, Francois; Pizer, Barry; Gustafsson, Göran; Navajas, Aurora; Massimino, Maura; Reddingius, Roel; Benesch, Martin; Carrie, Christian; Taylor, Roger; Gandola, Lorenza; Björk-Eriksson, Thomas; Giralt, Jordi; Oldenburger, Foppe; Pietsch, Torsten; Figarella-Branger, Dominique; Robson, Keith; Forni, Marco; Clifford, Steven C; Warmuth-Metz, Monica; von Hoff, Katja; Faldum, Andreas; Mosseri, Véronique; Kortmann, Rolf.
in: J CLIN ONCOL, Jahrgang 30, Nr. 26, 26, 2012, S. 3187-3193.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
AU - Lannering, Birgitta
AU - Rutkowski, Stefan
AU - Doz, Francois
AU - Pizer, Barry
AU - Gustafsson, Göran
AU - Navajas, Aurora
AU - Massimino, Maura
AU - Reddingius, Roel
AU - Benesch, Martin
AU - Carrie, Christian
AU - Taylor, Roger
AU - Gandola, Lorenza
AU - Björk-Eriksson, Thomas
AU - Giralt, Jordi
AU - Oldenburger, Foppe
AU - Pietsch, Torsten
AU - Figarella-Branger, Dominique
AU - Robson, Keith
AU - Forni, Marco
AU - Clifford, Steven C
AU - Warmuth-Metz, Monica
AU - von Hoff, Katja
AU - Faldum, Andreas
AU - Mosseri, Véronique
AU - Kortmann, Rolf
PY - 2012
Y1 - 2012
N2 - To compare event-free survival (EFS), overall survival (OS), pattern of relapse, and hearing loss in children with standard-risk medulloblastoma treated by postoperative hyperfractionated or conventionally fractionated radiotherapy followed by maintenance chemotherapy.
AB - To compare event-free survival (EFS), overall survival (OS), pattern of relapse, and hearing loss in children with standard-risk medulloblastoma treated by postoperative hyperfractionated or conventionally fractionated radiotherapy followed by maintenance chemotherapy.
KW - Humans
KW - Male
KW - Female
KW - Adolescent
KW - Child
KW - Survival Rate
KW - Combined Modality Therapy
KW - Disease-Free Survival
KW - Child, Preschool
KW - Recurrence
KW - Chemotherapy, Adjuvant
KW - Cranial Irradiation
KW - Radiotherapy, Adjuvant
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Cerebellar Neoplasms/radiotherapy
KW - Dose Fractionation
KW - Hearing Loss/etiology
KW - Medulloblastoma/radiotherapy
KW - Humans
KW - Male
KW - Female
KW - Adolescent
KW - Child
KW - Survival Rate
KW - Combined Modality Therapy
KW - Disease-Free Survival
KW - Child, Preschool
KW - Recurrence
KW - Chemotherapy, Adjuvant
KW - Cranial Irradiation
KW - Radiotherapy, Adjuvant
KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
KW - Cerebellar Neoplasms/radiotherapy
KW - Dose Fractionation
KW - Hearing Loss/etiology
KW - Medulloblastoma/radiotherapy
M3 - SCORING: Journal article
VL - 30
SP - 3187
EP - 3193
JO - J CLIN ONCOL
JF - J CLIN ONCOL
SN - 0732-183X
IS - 26
M1 - 26
ER -